Advisors Approve NCI Plan To Contract For Early Clinical Trials Of Imaging Agents.
NCI Recruits Carl Barrett Of NIEHS To Direct Basic Sciences; Freedman named to NCAB.
Sieber Direct Communications At NCI, Reorganizing Offices.
“5 A Day” Review Underway to Check Program’s Health at NCI.
AACR Honors Nine Cancer Researchers, Clinicians.
Cytogen Corp.’s Imaging Agent ProstaScint Added to NCCN Prostate Cancer Guidelines.
FDA Grants Six-Month Priority Review To Nolvadex For DCIS Adjuvant Treatment.
Bristol-Myers, Karolinska In Collaboration For Studies.
Antigenics Begins Phase II Trial Of Oncophage for NHL.
Aphton To Test Anti-Gastrin Drug At M. D. Anderson. NAS
RFP: Intellectual Property.
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Early-onset colorectal cancer is behaving like a new, biologically distinct disease, researchers note
One woman’s pregnancy shows how this distinction matters - More than 50 million Americans remain unscreened for colon cancer
New guidelines offer another option - Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data in ACS guideline support greater use of noninvasive tests to ease system strain, save lives - Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- Gonzalez-Angulo Found Guilty In MD Anderson Poisoning Case
